Experimental models of virus-induced demyelination

Handbook of Multiple Sclerosis, Third Edition

Volumn , Issue , 2001, Pages 67-113

  Dal Canto, Mauro C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84995622893     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (330)

1. Martin JR, Nathanson N. Animal models of virus-induced demyelination. In: Zimmerman HM, ed. Progress in Neuropathology. New York: Raven Press, 1979, pp. 27-50.
2. Dal Canto MC, Rabinowitz SG. Experimental models of virus-induced demyelination of the central nervous system. Ann Neurol 1982; 11:109-127.
3. Norrby E, Oxman MN. Measles virus. In: Fields BN, Knipe DM, eds. Fields Virology. New York: Raven Press 1990, pp. 1013-1044.
4. Koestner A, Long JF. Ultrastructure of canine distemper virus in explant tissue cultures of canine cerebellum. Lab Invest 1970; 23:196-201.
5. Raine CS. On the development of CNS lesions in natural canine distemper encephalomyelitis. J Neurol Sci 1976; 30:13-28.
6. Appel MJG. Pathogenesis of canine distemper. Am J Vet Res 1969; 30:1167-1182.
7. Wisniewski H, Raine CS, Kay WJ. Observations on viral demyelinating encephalomyelitis: Canine distemper. Lab Invest 1972; 26:589-599.
8. Vandevelde M, Zurbriggen A, Dumas M, Palmer D. Canine distemper does not infect oligodendrocytes in vitro. J Neurol Sci 1985; 69:133-137.
9. Zurbriggen A, Yamawaki M, Vandevelde M. Restricted canine distemper virus infection of oligodendrocytes. Lab Invest 1993; 68:277-284.
10. Graber HU, Muller CF, Vandevelde M, Zurbriggen A. Restricted infection with canine distemper virus leads to downregulation of myelin gene transcription in cultured oligodendrocytes. Acta Neuropathol 1995; 90:312-318.
11. Glaus T, Griot C, Richard A, Althaus U, Herschkowitz N, Vandevelde M. Ultrastructural and biochemical findings in brain cell cultures infected with canine distemper virus. Acta Neuropathol 1990; 80:59-67.
12. Zurbriggen A, Vandevelde M, Dumas M. Secondary degeneration of oligodendrocytes in canine distemper virus infection in vitro. Lab Invest 1986; 54:424-431.
13. Zurbriggen A, Vandevelde M, Bollo E. Demyelinating, non-demyelinating and attenuated canine distemper virus strains induce oligodendroglial cytolysis in vitro. J Neurol Sci 1987; 79:33-41.
14. Zurbriggen A, Vandevelde M, Bollo E. Demyelinating, non demyelinating and attenuated canine distemper virus strains induce oligodendroglial cytolysis in vitro. J Neurol Sci 1987; 79:33-41.
15. Rima BK, Duffy N, Mitchell WJ, Summers BA, Appel MJG. Correlation between humoral immune responses and presence of virus in the CNS in dogs experimentally infected with canine distemper virus. Arch Virol 1991; 121:1-8.
16. Duffy PE. Functional implications of astrocyte metabolism. In: Astrocytes: Normal, Reactive and Neoplastic. New York: Raven Press, 1983, pp. 39-41.
17. Zurbriggen A, Vandevelde M, Dumas M, Griot C, Bollo E. Oligodendroglial pathology in canine distemper virus infection in vitro. Acta Neuropathol (Berl) 1987; 74:366-373.
18. Summers BA, Greisen HA, Appel MJG. Early events in canine distemper demyelinating encephalomyelitis. Acta Neuropathol (Berl) 1979; 46:1-10.
19. Higgins RJ, Krakowka SG, Metzler AE, Koestner A. Primary demyelination in experimental canine distemper virus-induced encephalomyelitis in gnotobiotic dogs: Sequential immunologic and morphologic findings. Acta Neuropathol (Berl) 1982; 58:1-8.
20. Vandevelde M, Zurbriggen A, Higgins RJ, Palmer D. Spread and distribution of viral antigen in nervous canine distemper. Acta Neuropathol (Berl) 1985; 67:211-218.
21. Summers BA, Appel MJG. Demyelination in canine distemper encephalomyelitis: An ultrastructural analysis. J Neurocytol 1987; 16:871-881.
22. Zurbriggen A, Schmid I, Graber HU, Vandevelde M. Oligodendroglial pathology in canin distemper. Acta Neuropathol 1998; 95:71-77.
23. Bollo E, Zurbriggen A, Vandevelde M, Fankhauser R. Canine distemper virus clearance in chronic inflammatory demyelination. Acta Neuropathol 1986; 72:69-73.
24. Griot-Wenk M, Griot C, Pfister H, Vandevelde M. Antibody-dependent cellular cytotoxicity in anrtimyelin antibody-induced oligodendrocyte damage in vitro. J Neuroimmunol 1991; 33:145-155.
25. Griot C, Burge T, Vandevelde M, Peterhans E. Antibody-induced generation of reactive oxygen radicals by brain macrophages in canince distemper encephalitis: A mechanism of bystander demyelination. Acta Neuropathol 1989; 78:396-403.
26. Alldinger S, Wunschmann A, Baumgartner W, Voss C, Kremmer E. Up-regulation of major histocompatibility complex class II antigen expression in the central nervous system of dogs with spontaneous canine distemper encephalitis. Acta Neuropathol 1996; 92:273-280.
27. Wunschmann A, Alldinger S, Kremmer E, Baumgartner W. Identification of CD4+and CD8+ T cell subsets and B cells in the brain of dogs with spontaneous acute, subacute, and chronic demyelinating distemper encephalitis. Vet Immunol Immunopathol 1999; 67:101-116.
28. Tipold A, Moore P, Zurbriggen A, Burgener I, Barben G, Vandevelde M. Early T cell response in the central nervous system in canine distemper virus infection. Acta Neuropathol 1999; 97:4-56.
29. Frisk AL, Baumgartner W, Grone A. Dominating interleukin-10 mRNA expression induction in cerebrospinal fluid cells of dogs with natural canine distemper virus induced demyelinating and nondemyelinating CNS lesions. J Neuroimmunol 1999; 97:102-109.
30. Summers BA, Whitaker JN, Appel MJG. Demyelinating canine distemper encephalomyelitis: Measurement of myelin basic protein in cerebrospinal fluid. J Neuroimmunol 1987; 14:227-233.
31. Lisak RP, Zweiman B, Whitaker JN. Spinal fluid basic protein immunoreactive material and spinal fluid lymphocyte reactivity to basic protein. Neurology 1981; 31:180-182.
32. Johnson RT. Inflammatory and demyelinating diseases. In: Viral Infections of the Nervous System. New York: Raven Press, 1982, pp. 247-251.
33. Cook SD, Dowling PC. A possible association between house pets and multiple sclerosis. Lancet 1977; 1:980-982.
34. Cook SD, Natelson BH, Levin BE, Chavis PS, Dowling PC. Further evidence of a possible association between house dogs and multiple sclerosis. Ann Neurol 1978; 3:141-143.
35. Gilden DH, Wellish M, Rorke LB, Wroblewska Z. Canine distemper virus infection of weanling mice: Pathogenesis of CNS disease. J Neurol Sci 1981; 52:327-339.
36. McIntosh K. Coronaviruses: A comparative review. Curr Top Microbiol Immunol 1974; 63: 85-129.
37. Siddell SG, Wege H, ter Meulen V. The biology of coronaviruses. J Gen Virol 1983; 64: 761-776.
38. Tanaka R, Iwasaki Y, Koprowski H. Intracisternal virus-like particles in brain of a multiple sclerosis patient J Neurol Sci 1976; 128:121-126.
39. Burks JS, DeVald BL, Jankovsky LD, Gerdes JC. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science 1980; 209:933-934.
40. Murray RS, MacMillan B, Burks JS. Detection of coronavirus genome in the CNS of MS patients and control patients. Neurology 1987; 37(suppl 1):109.
41. Murray RS, Brown BS, Brian D, Cabirac GF. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol 1992; 31:525-533.
42. Lai MMC, Stohlman SA. RNA of mouse hepatitis virus. J Virol 1978; 26:236-242.
43. Lai MMC, Baric RS, Brayton PR, Stohlman SA. Characterization of leader RNA sequences on the virion and mRNAs on mouse hepatits virus, a cytoplasmic RNA virus. Proc Natl Acad Sci USA 1984; 81:3626-3630.
44. Lavi E, Murray EM, Makino S, Stohlman SA, Lai MM, Weiss SR. Determinants of coronavirus MHV pathogenesis are localized to 3' portion of the genome as determined by ribonucleic acid-ribonucleic acid recombination. Lab Invest 1990; 62:570-578.
45. Massa PT, Wege H, ter Meulen V. Analysis of murine hepatitis virus (JHM strain) tropism toward Lewis rat glial cells in vitro. Lab Invest 1986; 55:318-327.
46. Pasick JM, Dales S. Infection by coronavirus JHM of rat neurons and oligodendrocyte-type-2 astrocyte lineage cells during distinct developmental stages. J Virol 1991; 65:5013-5028.
47. Wang FI, Hinton DR, Gilmore W, Trousdale MD, Fleming JO. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab Invest 1992; 66:744-754.
48. Cheever FS, Daniels JB, Pappenheimer AM, Bailey OT. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin: I. Isolation and biological properties of the virus. J Exp Med 1949; 90:181-194.
49. LP. Weiner. Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus). Arch Neurol 1973; 28:298-303.
50. Lampert PW, Sims JK, Kniazeff AJ. Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol (Berl) 1973; 24:76-85.
51. Herndon RM, Griffin DE, McCormick U, Weiner LP. Mouse hepatitis virus-induced recurrent demyelination: A preliminary report. Arch Neurol 1975; 32:32-35.
52. Stohlman SA, Weiner LP. Stability of neurotropic mouse hepatitis virus (JHM strain) during chronic infection of neuroblastoma cells. Arch Virol 1978; 57:53-61.
53. Stohlman SA, Brayton PR, Fleming JO, Weiner LP, Lai MMC. Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J Gen Virol 1982; 63:265-275.
54. Erlich SS, Fleming JO, Stohlman SA, Weiner LP. Experimental neuropathology of chronic demyelination induced by a JHM virus variant (DS). Arch Neurol 1987; 44:839-842.
55. Haspel MV, Lampert PW, Oldstone MBA. Temperature sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proc Natl Acad Sci USA 1978; 75:4033-4036.
56. Knobler RL, Tunison LA, Lampert PW, Oldstone MBA. Selected mutants of mouse hepatitis virus type 4 (JHM strain) induce different CNS diseases. Am J Pathol 1982; 109:157-168.
57. Gallagher TM. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J Virol 1997; 71:3129-3137.
58. Gallagher TM, Escarmis C, Buchmeier MJ. Alteration of pH dependence of coronavirusinduced cell fusion: Effect of mutations in the spike glycoprotein. J Virol 1991; 65:1916-1928.
59. Gombold JL, Hingley ST, Weiss SR. Fusion defective mutants of mouse hepatitis virus A-59 contain a mutation in the spike protein cleavage signal. J Virol 1993; 67:4504-4512.
60. Phillips JJ, Chua MM, Lavi E, Weiss SR. Pathogenesis of chimeric MHV4/MHV-A-59 recombinant viruses: The murine coronavirus spike protein is a major determinant of neurovirulence. J Virol 1999; 73:7752-7760.
61. Rowe CL, Baker SC, Nathan MJ, Sgro JY, Palmenberg AC, Fleming JO. Quasispecies development by high frequency RNA recombination during MHV persistence. Adv Exp Med Biol 1998; 440:759-765.
62. Rowe CL, Fleming JO, Nathan MJ, Sgro JY, Palmenberg AC, Baker SC. Generation of coronavirus spike deletion variants by high frequency recombination at regions of predicted RNA secondary structure. J Virol 1997; 71:6183-6190.
63. Arbour N, Cote G, Lachance C, Tardieu M, Cashman NR, Talbot PJ. Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol 1999; 73:3338-3350.
64. Pewe L, Xue S, Perlman S. Cytotoxic T-cell-resistant variants arise at early times after infection in C57B1/6 but not SCID mice infected with a neurotropic coronavirus. J Virol 1997; 71:7640-7647.
65. Pewe L, Xue S, Perlman S. Infection with cytotoxic T lymphocyte escape mutants results in increased mortality and growth retardation in mice infected with a neurotropic coronavirus. J Virol 1998; 72:5912-5918.
66. Pewe L, Perlman S. Immune response to the immunodominant epitope of mouse hepatitis virus is polyclonal, but functionally monospecific in C57B1/6 mice. Virology 1999; 255: 106-116.
67. Pewe L, Heard SB, Bergmann C, Dailey M, Perlman S. Selection of CTL escape mutants in mice infected with a neurotropic coronavirus: Quantitative estimate of TCR diversity in the infected central nervous system. J Immunol. In press.
68. Wang FI, Stohlman SA, Fleming JO. Demyelination induced by murine hepatitis virus JHM sttrain (MHV-4) is immunologically mediated. J Neuroimmunol 1990; 30:31-41.
69. Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL. Murine hepatitis virus-4 (strain JHM) induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 1984; 132:261-270.
70. Fleming JO, Trousdale MD, El-Zaatari FAK, Stohlman SA, Weiner LP. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 1986; 58:869-875.
71. Dalziel RG, Lampert PW, Talbot PJ, Buchmeier MJ. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J Virol 1986; 59:463-471.
72. Wege H, Winter J, Meyermann R. The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis. J Gen Virol 1988; 69:87-98.
73. Yokomori K, Stohlman SA, Lai MM. The detection and characterization of multiple hemagglutinin-esterase (HE)-defective viruses in the mouse brain during subacute demyelination induced by mouse hepatitis virus. Virology 1993; 192:170-178.
74. Schwender S, Imrich H, Dorries R. The pathogenetic role of virus-specific antibody-secreting cells in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis. Immunology 1991; 74:533-538.
75. Lin MT, Hinton DR, Marten NW, Bergmann CC, Stohlman SA. Antibody prevents virus reactivation within the central nervous system. J Immunol 1999; 162:7358-7368.
76. Zimprich F, Winter J, Wege H, Lassmann H. Coronavirus-induced primary demyelination: Indication for the involvement of a humoral immune response. Neuropathol Appl Neurobiol 1991; 17:469-484.
77. Flory E, Pfleiderer M, Stuhler A, Wege H, Wege H. Induction of protective immunity against coronavirus-induced encephalomyelitis. Evidence for an importanr role of CD8+ T-cells in vivo. Eur J Immunol 1993; 23:1757-1761.
78. Suzumura A, Lavi E, Weiss SR, Silberberg DH. Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science 1986; 232:991-993.
79. Correale J, Li S, Weiner LP, Gilmore W. Effect of persistent mouse hepatitis virus infection on MHC class I expression in murine astrocytes. J Neurol Sci 1995; 40:10-21.
80. Lavi E, Suzumura A, Lampson LA, Siegel RM, Murasko DM, Silberberg DH, Weiss SR. Expression of MHC class I genes in mouse hepatitis virus infection and in multiple sclerosis. Adv Exp Med Biol 1987; 218:219-222.
81. Massa PT, Dörries R, ter Meulen V. Viral particles induce Ia antigen expression on astrocytes. Nature 1986; 320:543-546.
82. Gombold JL and Weiss SR. Mouse hepatits virus A59 increases steady state levels of MHC mRNAs in primary glial cell sultures and in the murine central nervous system. Microb Pathogen 1992; 13:493-505.
83. Marten NW, Stohlman SA, Smith-Begolka W, Miller SD, Dimacali E, Yao Q, Stohl S, Goverman J, Bergmann CC. Selection of CD8 T cells with highly focused specificity during viral persistence in the central nervous system. J Immunol 1999; 162:3905-3914.
84. Stohlman SA, Bergmann CC, Cua DJ, Lin MT, Ho S, Wei W, Hinton DR. Apoptosis of JHMV-specific CTL in the CNS in the absence of CD4 T cells. Adv Exp Med Biol 1998; 440:425-430.
85. Lavi E, J Das Sarma, Weiss SR. Cellular reservoirs for coronavirus infection of brain in beta2-microglobulin knockout mice. Pathobiology 1999; 67:75-83.
86. Lin MT, Hinton DR, Stohlman SA. Mechanisms of viral clearance in perforin-deficient mice. Adv Exp Med Biol 1998; 440:431-436.
87. Wang Q, Haluskey JA, Lavi E. Coronavirus MHV-A-59 causes upregulation of interferonbeta RNA in primary glial cell cultures. Adv Exp Med Biol 1998; 440:451-454.
88. Lin MT, Hinton DR, Parra B, Stohlman SA, van der Veen RC. The role of IL-10 in mouse hepatitis virus-induced demyeliating encephalomyelitis. Virology 1998; 245:270-280.
89. Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, CS Yang, Stohlman SA. IFNgamma is required for viral clearance from central nervous system oligodendroglia. J Immunol 1999; 162:1641-1647.
90. Parra B, Hinton DR, Lin MT, Cua DJ, Stohlman SA. Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology 1997; 233:260-270.
91. Wege H, Schluesener H, Meyermann R, Barac-Latas V, Suchanek G, Lassmann H. Coronavirus infection and demyelination: Development of inflammatory lesions in Lewis rats. Adv Exp Med Biol 1998; 440:437-444.
92. Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, MJ Buchmeier. Dynamic regulation of alpha-and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 1998; 160:970-978.
93. Lane TE, Fox HS, Buchmeier MJ. Inhibition of nitric oxide synthase-2 reduces the severity of mouse hepatitis virus-induced demyelination: Implications for NOS2/NO regulation of chemokine expression and inflammation. J Neurovirol 1999; 5:48-54.
94. Wu GF, Perlman S. Macrophage infiltration, but not apoptosis, is correlated with immunemediated demyelination following murine infection with a neurotropic coronavirus. J Virol 1999; 73:8771-8780.
95. Xue S, Sun N, Van N Rooijen, Perlman S. Depletion of blood-borne macrophages does not reduce demyelination in mice infected with a neurotropic coronavirus. J Virol 1999; 73: 6327-6334.
96. Nagashima K, Wege H, Meyermann R, ter Meulen V. Coronavirus induced subacute demyelinating encephalomyelitis in rats: A morphological analysis. Acta Neuropathol 1978; 44: 63-70.
97. Wege H, Watanabe R, ter Meulen V. Relapsing subacute demyelinating encephalomyelitis in rats during the course of coronavirus JHM infection. J Neuroimmunol 1984; 6:325-336.
98. Sorensen O, Percy D, Dales S. In vivo and in vitro models of demyelinating diseases: III. JHM virus infection of rats. Arch Neurol 1980; 37:478-484.
99. Wege H, Koga M, Watanabe R, Nagashima K, ter Meulen V. Neurovirulence of murine coronavirus JHM temperature sensitive mutants in rats. Infect Immun 1983; 39:1316-1324.
100. Koga M, Wege H, ter Meulen V. Sequence of murine coronavirus JHM induced neuropathological changes in rats. Neuropathol Appl Neurobiol 1984; 10:173-184.
101. Watanabe R, Wege H, ter Meulen V. Adoptive transfer of EAE-like lesions from rats vith coronavirus induced demyelinating encephalomyelitis. Nature (London) 1983; 305:150-153.
102. Massa PT, Brinkmann R, ter Meulen V. Inducibility of Ia antigen on astrocytes by murine coronavirus JHM is rat strain dependent. J Exp Med 1987; 166:259-264.
103. Wekerle H, Kojima K, Lannes-Viera J, Lassmann H, Linington C. Animal models. Ann Neurol 1994; 36:S47-S53.
104. Harter DH. The detailed structure of visna-maedi virus. In: Kimberlin RH, ed. Slow Virus Diseases of Animals and Man. Amsterdam and New York: North Holland, 1976, pp 45-60.
105. Sigurdsson B. Observations on three slow infections of sheep. Br Vet J 1954; 110:255-270.
106. Haase AT. Pathogenesis of lentivirus infections. Nature 1986; 322:130-136.
107. Carruth LM, Morse BA, Clements JE. The leucine domain of the visna virus Tat protein mediates targeting to an AP-1 site in the viral long terminal repeat. J Virol 1996; 70:4338-4344.
108. Carruth LM, Clements JE. Targeting of the visna virus Tat protein to AP-1 sites: Interaction with the bZIP domains of fos and jun in vitro and in vivo. J Virol 1999; 137-145.
109. Sigurdsson B, Thormar H, Palsson PA. Cultivation of visna virus in tissue culture. Arch Gesamte Virusforsch 1960; 10:368-381.
110. Georgsson G, Palsson PA, Petursson G. Pathogenesis of visna. In: Serlupi Crescenzi G, ed. A multidisciplinary approach to myelin disease. New York: Plenum, 1987, pp. 303-318.
111. Narayan O, Griffin DE, Chase J. Antigenic drift of visna virus in persistently infected sheep. Science 1977; 197:376-378.
112. Lutley R, Petursson G, Palsson PA, Georgsson G, Klein J, Nathanson N. Antigenic drift in visna virus variation during long term infection of islandic sheep. J Gen Virol 1983; 64: 1433-1440.
113. Haase AT, Stowring L, Narayan O, Griffin D, Price D. Slow persistent infection caused by visna virus: Role of host restriction. Science 1977; 195:175-177.
114. Haase AT. The role of active and covert infections in lentivirus pathogenesis. In: Bjornsson J, Carp RI, Love A, Wisniewski HM, eds. Slow Infections of the Central Nervous System. New York Annals of the New York Academy of Sciences, 1994; 724:75-86.
115. Vigne R, Neuveut C, Sire J, Philippon V, Filippi P. Involvement of viral regulatory gene products in the pathogenesis of lentivirus infections. In: Bjornsson J, Carp RI, Love A, Wisniewski HM, eds. Slow Infections of the Central Nervous System. New York: Annals of the New York Academy of Sciences, 1994; 724:107-124.
116. Eriksson K, McInnes E, Ryan S, Tonks P, McConnell I, Blacklaws B. CD4+ T cells are required for the establishment of maedi-visna virus infection in macrophages but not dendritic cells in vivo. Virology 1999; 248:355-364.
117. Chebloune Y, Karr BM, Raghavan R, Singh DK, Leung K, Sheffer D, Pinson D, Foresman L, Narayan O. Neuroinvasion by ovine lentivirus in infected sheep mediated by inflammatory cells associated with experimental allergic encephalomyelitis. J Neurovirol 1998; 4:38-48.
118. Petursson G, Nathanson N, Georgsson G, Panitch H, Palsson PA. Pathogenesis of Visna I. Sequential virologic, serologic and pathologic studies. Lab Invest 1976; 35:402-412.
119. Palsson PA. Maedi and visna in sheep. In Kimberlin RH, ed. Slow Virus Diseases of Animals and Man. Amsterdam and New York: North Holland, 1976, pp. 7-43.
120. Georgsson G, Nathanson N, Palsson PA, Petursson G. The pathology of visna and maedi in sheep. In: Kimberlin RH, ed. Slow Virus Diseases of Animals and Man. Amsterdam and New York: North Holland, 1976, pp. 61-96.
121. Nathanson N, Georgsson G, Palsson PA, Najjar JA, Lutley R, Petursson G. Experimental visna in islandic sheep: The prototype lentiviral infection. Rev Infect Dis 1985; 7:75-82.
122. Nathanson N, Petursson G, Georgsson G, Palsson PA, Martin JR, Miller A. Pathogenesis of visna: IV. Spinal fluid studies. J Neuropathol Exp Neurol 1979; 38:197-208.
123. Georgsson G, Martin JR, Klein J, Palsson PA, Nathanson N, Petursson G. Primary demyelination in visna: An ultrastructural study of islandic sheep with clinical signs following experimental infection. Acta Neuropathol (Berl) 1982; 57:171-178.
124. Nathanson N, Panitch H, Palsson PA, Petursson G, G Georgsson. Pathogenesis of visna: II. Effect of immunosuppression upon early central nervous system lesions. Lab Invest 1976; 35:444-451.
125. Petursson G, Nathanson N, Palsson PA, Martin J, Georgsson G. Immunopathogenesis of visna. A slow virus disease of the central nervous system. Acta Neurol Scand 1978; 57(suppl 67):205-219.
126. Nathanson N, Martin JR, Georgsson G, Palsson PA, Lutley R, Petursson G. Effect of postinfection immunization on the severity of experimental visna. J Comp Pathol 1981; 91:185-191.
127. Davies JM, Watt NJ, Torsteinsdottir S, Carnegie PR. Mimicry of a 21.5 kDa myelin protein peptide by a Maedi Visna virus polymerase peptide does not contribute to the pathogenesis of encephalitis in sheep. Vet Immunol Immunopathol 1996; 55:127-139.
128. Lutley R, Petursson G, Georgsson G, Palsson PA, Nathanson N. Strains of visna virus with increased neurovirulence. In: Sharp JM, Hoff-Jörgensen R, eds. Slow Viruses in Sheep, Goats and Cattle. Luxembourg: Commission of the European Communities, 1985, pp. 45-49.
129. Georgsson G, Houwers DJ, Palsson PA, Petursson G. Expression of viral antigens in the central nervous system of visna infected sheep: An immunohistochemical study on experimental visna induced by virus strains of increased neurovirulence. Acta Neuropathol. In press.
130. Stowring L, Haase AT, Petursson G, Georgsson G, Palsson P, Lutley R, Roos R, Szuchet S. Detection of visna virus antigens and RNA in glial cells in foci of demyelination. Virology 1985; 141:311-318.
131. Georgsson G. Neuropathologic aspects of lentiviral infections. In: Bjornsson J, Carp RI, Love A, Wisniewski HM, eds. Slow infections of the central nervous system. New York: Annals of the New York Academy of Sciences, 1994; 724:50-67.
132. Torsteinsdottir S, Georgsson G, Gisladottir E, Rafnar B, Palsson PA, Peturson G. Pathogenesis of central nervous system lesions in visna: Cell-mediated immunity and lymphocyte subsets in blood, brain and cerebrospinal fluid. J Neuroimmunol 1992; 41:149-158.
133. Torsteinsdottir S, Georgsson G, Gisladottir E, Rafnar B, Palsson PA, Peturson G. Pathogenesis of central nervous system lesions in visna. Cell-mediated immunity and lymphocyte subsets in blood, brain, and cerebrospinal fluid. In: Bjornsson J, Carp RI, Love A, Wisniewski HM, eds. Slow infections of the central nervous system. New York: Annals of the New York Academy of Sciences, 1994; 724:159-161.
134. Bergsteinsdottir K, Arnadottir S, Torsteinsdottir S, Agnarsdottir G, Andresdottir V, Pettursson G, Georgsson G. Constitutive and visna virus induced expression of class I and II major histocompatibility complex antigens in the central nervous system of sheep and their role in the pathogenesis of visna lesions. Neuropathol Appl Neurobiol 1998; 24:224-232.
135. Craig LE, Sheffer D, Meyer AL, Hauer D, Lechner F, Peterhans E, Adams RJ, Clements JE, Narayan O, MC. Pathogenesis of ovine lentiviral encephalitis: Derivation of a neurovirulent strain by in vivo passage. J Neurovirol 1997; 3:417-427.
136. Starling I, Wright A, Arbuthnott G, Harkiss G. Acute in vivo neurotoxicity of peptides from Maedi Visna virus transactivating protein Tat. Br Res 1999; 830:285-291.
137. Andrewes CH, Pereira HG, Wildy P. Herpetoviridae. In: Andrewes CH, Pereira HG, Wildy P, eds. Viruses of Vertebrates. London: Bailliere Tindall 1978, pp. 312-355.
138. Nahmias AJ, Dowdle WR. Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol 1968; 10:110-159.
139. Stevens JG, Cook ML. Latent herpes simplex virus in spinal ganglia of mice. Science 1971; 173:843-845.
140. Stevens JG, Nesburn AB, Cook ML. Latent herpes simplex virus from trigeminal ganglia of rabbits with recurrent eye infection. Nature 1972; 235:216-217.
141. Bastian FO, Rabson AS, Yee CL, Tralka TS. Herpes virus hominis: Isolation from human trigeminal ganglion. Science 1972; 178:306-307.
142. Warren KG, Brown SM, Wroblewska Z, Gilden D, Koprowski H, Subak-Sharpe J. Isolation of latent herpes simplex virus from the superior cervical and vagus ganglions of human beings. N Engl J Med 1978; 298:1068-1069.
143. Baringer JR. Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med 1974; 291:828-830.
144. Kristensson K, Vahlne A, Persson LA, Lycke E. Neural spread of herpes simplex virus types 1 and 2 in mice after corneal or subcutaneous (footpad) inoculation. J Neurol Sci 1978; 35: 331-340.
145. Townsend JJ, Baringer JR. Central nervous system susceptibility to herpes simplex virus infection. J Neuropathol Exp Neurol 1978; 37:255-262.
146. Kristensson K, Svennerholm B, Persson L, Vahlne A, Lycke E. Latent herpes simplex virus trigeminal ganglionic infection in mice and demyelination in the central nervous system. J Neurol Sci 1979; 43:253-264.
147. Townsend JJ, Baringer JR. Morphology of central nervous system disease in immunosuppressed mice after peripheral herpes simplex virus inoculation: Trigeminal root entry zone. Lab Invest 1979; 40:178-182.
148. Townsend JJ. The demyelinating effect of corneal HSV infections in normal and nude (athymic) mice. J Neurol Sci 1981; 50:435-441.
149. Kristensson K, Thormar H, Wisniewski HM. Myelin lesions in the rabbit eye model as a bystander effect of herpes simplex and visna virus sensitization. Acta Neuropathol (Berl) 1979; 48:215-217.
150. Kristensson K, Svennerholm B, Vahlne A, Nilheden E, Persson L, Lycke E. Virus induced demyelination in herpes symplex virus infected mice. J Neurol Sci 1982; 53:205-216.
151. Townsend JJ. The relationship of astrocytes and macrophages to CNS demyelination after experimental herpes simplex infection. J Neuropathol Exp Neurol 1981; 40:369-379.
152. Townsend JJ. Macrophage response to herpes simplex encephalitis in immune-competent and T-cell deficient mice. J Neuroimmunol 1985; 7:195-206.
153. Gudmundsdottir S, Svennerholm B, Kristensson K, Lycke E. Herpes simplex virus-enhanced production of autoantibodies against myelin basic protein in mice. Arch Virol 1986; 88:37-47.
154. Kristensson K, Svennerholm B, Lycke E. Herpes simplex virus-induced demyelination: Effect of reinfection and challenge with neuroantigens. J Neurol Sci 1983; 60:247-252.
155. Kastrukoff LF, Lau AS, Leung GY, Thomas EE. Contrasting effects of immunosuppression on herpes simplex virus type I (HSV I) induced central nervous system (CNS) demyelination in mice. J Neurol Sci 1993; 117:148-158.
156. Kastrukoff LF, Lau AS, Leung GY, Walker DG, Thomas EE. Herpes simplex virus type I (HSV-I)-induced multifocal central nervous system (CNS) demyelination in mice. J Neuropathol Exp Neurol 1992; 51:432-439.
157. Kastrukoff LF, Lau AS, Kim SU. Multifocal CNS demyelination following peripheral inoculation with herpes simplex virus type 1. Ann Neurol 1987; 22:52-59.
158. Thomas EE, Lau AS, Kim SU, Osborne D, Kastrukoff LF. Variation in resistance to herpes simplex virus type 1 of oligodendrocytes derived from inbred strains of mice. J Gen Virol 1991; 72:2051-2057.
159. Thomas EE, Lau AS, Morrison B, Kim SU, Kastrukoff LF. Differences in resistance to herpes simplex virus type 1 (HSV-1) among oligodendroglia derived from different strains of mice are determined after viral absorption but prior to the expression of immediate early (IE) genes. J Neurovirol 1997; 3:197-205.
160. Martin JR, Stoner GL, Webster H de F. Lethal encephalitis and non-lethal multifocal central nervous system demyelination in herpes simplex virus type 2 infections in mice. Br J Exp Pathol 1982; 63:651-666.
161. Martin JR, Stoner GL. The nervous system in genital herpes simplex type 2 infections in mice. Lethal panmyelitis or non-lethal demyelinative myelitis or meningitis. Lab Invest 1984; 51:556-566.
162. Martin JR, Reed EV, Striegel LC. Acute thymic atrophy in severe herpes simplex virus type 2 infection. In: Gilmore N, M Wainberg, eds. Viral mechanisms of immunosuppression. New York: Liss, 1985:185-190.
163. Gudnadottir M, Helgadottir H, Bjarnason O, Jonsdottir K. Virus isolated from the brain of a patient with multiple sclerosis. Exp Neurol 1964; 9:85-89.
164. Martin JR, Suzuki S, Webster H de F. Central nervous system demyelination in herpes sim plex virus type 2 infection. In: Serlupi-Crescenzi G, ed. A Multidisciplinary Approach to Myelin Diseases. New York and London: Plenum, 1987, pp. 329-340.
165. Martin JR. Intra-axonal virus in demyelinative lesions of experimental herpes simplex type 2 infection. J Neurol Sci 1984; 63:63-74.
166. Georgsson G, Martin JR, Stoner GL, Webster H de F. Virus spread and initial pathological changes in the nervous system in genital herpes simplex type 2 infection in mice. Acta Neuropathol (Berl) 1987; 72:377-388.
167. Martin JR, Reed EV. Central nervous system and genital infection with reactivation of latent herpes simplex virus type 2 in mice. Microb Pathog 1986; 1:181-189.
168. Martin JR, Suzuki S. Inflammatory sensory polyradiculopathy and reactivated peripheral nervous system infection in a genital herpes model. J Neurol Sci 1987; 79:155-171.
169. Soffer D, Martin JR. Remyelination of central nervous system lesions in experimental genital herpes simplex virus infection. J Neurol Sci 1988; 86:83-95.
170. Martin JR, Suzuki S. Targets of infection in a herpes simplex reactivation model. Acta Neuropathol 1989; 77:402-411.
171. Suzuki S, Martin JR. Herpes simplex virus type 2 transcripts in trigeminal ganglia during acute and latent infection in mice. J Neurol Sci 1989; 93:239-251.
172. Gressens P, Martin JR. HSV-2 DNA persistence in astrocytes of the trigeminal root entry zone: Double labeling by in situ PCR and immunohistochemistry. J Neuropathol Exp Neurol 1994; 53:127-135.
173. Subak-Sharpe J, Koprowski H. Isolation of herpes simplex virus from human trigeminal ganglia, including ganglia from one patient with multiple sclerosis. Lancet 1977; 2:637-639.
174. Nicoll JAR, Kinrade E, Love S. PCR-mediated search for herpes simplex virus DNA in sections of brain from patients with multiple sclerosis and other neurological disorders. J Neurol Sci 1992; 113:144-151.
175. Koenig H, Rabinowitz SG, Day E, Miller V. Post-infectious encephalomyelitis after successful treatment of herpes simplex encephalitis with adenine arabinoside: Ultrastructural observations. N Engl J Med 1979; 300:1089-1093.
176. Martin JR. Herpes simplex virus types 1 and 2 and multiple sclerosis. Lancet 1981; 2:777-781.
177. Pevear DC, Calenoff M, Rozhon E, Lipton HL. Analysis of the complete nucleotide sequence of the picornavirus Theiler’s murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol 1987; 61:1507-1516.
178. Ozden S, Tangy F, Chamorro M, Brahic M. Theiler’s virus genome is closely related to that of encephalomyiocarditis virus, the prototype cardiovirus. J Virol 1986; 60:1163-1165.
179. Ohara Y, Stein S, Fu J, Stillman L, Klaman L, Roos RP. Molecular cloning and sequence determination of DA strain of Theiler’s murine encephalomyelitis viruses. Virology 1988; 164:245-255.
180. Roos RP, Richard OC, Ehrenfeld E. Analysis of Theiler’s virus isolates from persistently infected mouse nervous tissue. J Gen Virol 1983; 64:701-706.
181. Roos RP, Richards OC, Green J, Ehrenfeld E. Characterization of a cell culture persistently infected with the DA strain of Theiler’s murine encephalomyelitis virus. J Virol 1982; 43: 1118-1122.
182. Theiler M. Spontaneous encephalomyelitis of mice, a new virus disease. J Exp Med 1937; 65:705-719.
183. Lorch Y, Friedmann A, Lipton HL, Kotler M. Theiler’s murine encephalomyelitis virus group includes two distinct genetic subgroups that differ pathologically and biologically. J Virol 1981; 40:560-567.
184. Lipton HL. Persistent Theiler’s murine encephalomyelitis virus infection in mice depends on plaque size. J Gen Virol 1980; 46:169-177.
185. Friedmann A, Lipton HL. Replication of Theiler’s murine encephalomyelitis viruses in BHK21 cells: An electron microscopic study. Virology 1980; 101:389-398.
186. Dal.Canto MC, Lipton HL. Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler’s virus infection. Am J Pathol 1982; 106:20-29.
187. Cash E, Chamorro M, Brahic M. Theiler’s virus RNA and protein synthesis in the central nervous system of demyelinating mice. Virology 1985; 144:290-294.
188. Brahic M, Stroop WG, Baringer JR. Theiler’s virus persists in glial cells during demyelinating disease. Cell 1981; 26:123-128.
189. Pevear DC, Borkowski J, Calenoff M, Oh CK, Ostrowski B, Lipton HL. Insights into Theiler’s virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains. Virology 1988; 165:1-12.
190. Pevear DC, Luo M, Lipton HL. Three-dimensional model of the capsid proteins of two biologically different Theiler’s virus strains: Clustering of aminoacis differences identifies possible locations of immunogenic sites on the virion. Proc Natl Acad Sci USA 1988; 85:4496-4500.
191. Dal Canto MC, Lipton HL. Schwann cell remyelination and recurrent demyelination in the central nervous system of mice infected with attenuated Theiler’s virus. Am J Pathol 1980; 98:101-122.
192. Lipton HL. Theiler’s virus infection in mice: An unusual biphasic disease process leading to demyelination. Infect Immun 1975; 11:1147-1155.
193. Dal Canto MC, Lipton HL. Primary demyelination in Theiler’s virus infection. Lab Invest 1976; 33:626-637.
194. Lipton HL, Dal Canto MC. Chronic neurologic disease in Theiler’s virus infection of SJL/J mice. J Neurol Sci 1976; 30:201-207.
195. Lipton HL, Dal Canto MC. Theiler’s virus induced demyelination: Prevention by immunosuppression. Science 1976; 192:62-64.
196. HL Dal Canto, Dal Canto MC. The TO strain of Theiler’s viruses cause '‘slow virus like’’ infection in mice. Ann Neurol 1979; 6:25-28.
197. Dal Canto MC, Melvold RW, Kim BS, Miller SD. Two models of multiple sclerosis: Experimental allergic encephalomyelitis (EAE) and Theiler’s murine encephalomyelitis virus (TMEV) infection-A pathological and immunological comparison. J Micr Res Tech. In press.
198. Dal Canto MC, Melvold RW, Kim BS. A hybrid between a resistant and a susceptible strain of mouse alters the pattern of Theiler’s murine encephalomyelitis virus-induced white matter disease and favors oligodendrocyte-mediated remyelination. Mult Scler 1995; 1:95-103.
199. Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M. Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 1994; 14: 6230-6238.
200. Asakura K, Miller DJ, Pease LR, Rodriguez M. Targeting of IgM kappa antibodies to oligodendrocytes promotes CNS remyelination. J Neurosci 1998; 18:7700-7708.
201. Clatch RJ, Melvold RW, Miller SD, Lipton HL. Theiler’s murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H2-D region: Correlation with TMEV-specific delayed-type hypersensitivity. J Immunol 1985; 135:1408-1414.
202. Rodriguez M, Leibowitz J, David CS. Susceptibility to Theiler’s virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med 1986; 163:620-631.
203. Melvold RW, Jokinen DM, Miller SD, Dal Canto MC, Lipton HL. H-2 genes in TMEVinduced demyelination, a model for multiple sclerosis. In: David C, ed. Major Histocompatibility Genes and Their Role in Immune Function. New York: Plenum, (1987), pp. 735-745.
204. Clatch RJ, Melvold RW, Dal Canto MC, Miller SD, Lipton HL. The Theiler’s murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B, and C. J Neuroimmunol 1987; 15:121-135.
205. Lipton HL, Dal Canto MC. Susceptibility of inbred mice to chronic central nervous system infection by Theiler’s murine encephalomyelitis virus. Infect Immun 1979; 26:369-374.
206. Lipton HL, Melvold RW. Genetic analysis of susceptibility to Theiler’s virus induced demyelinating disease in mice. J Immunol 1984; 132:1821-1825.
207. Melvold RW, Jokinen DM, Knobler R, Lipton HL. Variations in genetic control of susceptibility to Theiler’s murine encephalomyelitis virus (TMEV)-induced demyelinating disease: I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T cell ß-chain constant genes on chromosome 6. J Immunol 1986; 138:1429-1433.
208. Kappel CA, Dal Canto MC, Melvold RW, Kim BS. Hierarchy of effects of the major histocompatibility complex and the T cell receptor ß-chain genes in susceptibility to Theiler’s murine encephalomyelitis virus-induced demyelinating disease. J Immunol 1991; 147:4322-4326.
209. Melvold RW, Jokinen DM, Miller SD, Dal Canto MC, Lipton HL. Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler’s murine encephalomyelitis virus (TMEV)-induced demyelinating disease. J Virol 1990; 64:686-690.
210. Aubagnac S, Brahic M, Bureau J-F. Viral load and a locus on chromosome 11 affect the late clinical disease caused by Theiler’s virus. J Virol 1999; 73:7965-7971.
211. Bureau JF, Drescher KM, Pease LR, Vikoren T, Delcroix M, Zoecklein L, Brahic M, Rodriguez M. Chromosome 14 contains determinants that regulate susceptibility to Theiler’s virusinduced demyelination in the mouse. Genetics 1998; 148:1941-1949.
212. Bihl F, Brahic M, Bureau JF. Two loci, Tmevp2 and Tmevp3, located on the telomeric region of chromosome 10, control the persistence of Theiler’s virus in the central nervous system of mice. Genetics 1999; 152:385-392.
213. Kappel CA, Melvold RW, Kim BS. Influence of sex on susceptibility in Theiler’s murine encephalomyelitis virus model for multiple sclerosis. J Neuroimmunol 1990; 29:15-19.
214. Rodriguez M, Patick AK, Pease LR. Abrogation of resistance to Theiler’s virus-induced demyelination in C57BL mice by total body irradiation. J Neuroimmunol 1990; 26:189-199.
215. Nicholson MN, Paterson JD, Miller SD, Wang K, Dal Canto MC, Melvold RW. BALB/c substrain differences in susceptibility to Theiler’s murine encephalomyelitis virus-induced demyelinating disease. J Neuroimmunol 1994; 52:19-24.
216. Olsberg C, Pelka A, Miller S, Waltenbaugh C, Creighton TM, Dal Canto MC, Lipton H, Melvold RW. Induction of Theiler’s murine encephalomyelitis virus (TMEV)-induced demyelinating disease in genetically resistant mice. Reg Immunol 1993; 5:1-10.
217. Pelka A, Olsberg C, Miller S, Waltenbaugh C, Creighton TM, Dal Canto MC, Melvold R. Effects of irradiation on development of Theiler’s murine encephalomyelitis virus (TMEV)-induced demyelinating disease in genetically resistant mice. Cell Immunol 1993; 152: 440-455.
218. Nicholson S, Dal Canto MC, Miller SD, Melvold RW. Adoptively transferred CD8+ T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice. J Immunol 1996; 156:1276-1283.
219. Fiette L, Aubert C, Brahic M, Rossi CP. Theiler’s virus infection of beta 2-microglobulindeficient mice. J Virol 1993; 67:589-592.
220. Rodriguez M, Dunkel AJ, Thiemann RL, Leibowitz J, Zijlstra M, Jaenisch R. Abrogation of resistance to Theiler’s virus-induced demyelination in H-2b mice deficient in B2-microglobulin. J Immunol 1993; 151:266-276.
221. Pullen LC, Miller SD, Dal Canto MC, Kim BS. Class I deficient resistant mice intracerebrally inoculated with Theiler’s virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur J Immunol 1993; 23:2287-2293.
222. Murray PD, McGavern DB, Lin X, Njenga MK, Leibowitz J, Pease LR, Rodriguez M. Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J Neurosci 1998; 18:7306-7314.
223. Chen HH, Kong WP, Zhang I, Ward PL, Roos RP. A picornaviral protein synthesized out of frame with the polyprotein plays a key role in a virus-induced immune-mediated demyelinating disease. Nature Med 1995; 1:927-931.
224. Ghadge GD, Ma L, Sato S, Kim J, Roos RP. A protein critical for a Theiler’s virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence. J Virol 1998; 72:8605-8612.
225. Adami C, Pritchard AE, Knauf T, Luo M, Lipton HL. A determinant for central nervous system persistence localized in the capsid of Theiler’s murine encephalomyelitis virus by using recombinant viruses. J Virol 1998; 72:1662-1665.
226. Clatch RJ, Lipton HL, Miller SD. Characterization of Theiler’s murine encephalomyelitis virus (TMEV)-specific delayed type hypersensitivity responses in TMEV-induced demyelinating disease: Correlation with clinical signs. J Immunol 1986; 136:920-927.
227. Rodriguez M, Leibowitz JL, Lampert P. Persistent infection of oligodendrocytes in Theiler’s virus-induced encephalomyelitis. Ann Neurol 1983; 13:426-433.
228. Rodriguez M, Pease LR, David CS. Immune mediated injury of virus-infected oligodendrocytes. Immunol Today 1986; 7:359-363.
229. Dal Canto MC. Uncoupled relationship between demyelination and primary infection of myelinating cells in Theiler’s virus encephalomyelitis. Infect Immun 1982; 35:1133-1138.
230. Dal Canto MC, Barbano RL. Immunocytochemical localization of MAG, MBP and Po protein in acute and relapsing demyelinating lesions of Theiler’s virus infection. J Neuroimmunol 1985; 10:129-140.
231. Penney JB, Wolinsky JS. Neuronal and oligodendroglial infection by theWWstrain of Theiler’s virus. Lab Invest 1979; 40:324-330.
232. Rosenthal A, Fujinami RS, Lampert PW. Mechanism of Theiler’s virus-induced demyelination in nude mice. Lab Invest 1986; 54:515-522.
233. Clatch RJ, Miller SD, Metzner R, Dal Canto MC, Lipton HL. Monocyte/macrophages isolated from the mouse CNS contain infectious Theiler’s murine encephalomyelitis virus (TMEV). Virology 1990; 176:244-254.
234. Pope JG, Vanderlugt CL, Rahbe SM, Lipton HL, Miller SD. Characterization of, and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler’s murine encephalomyelitis virus. J Virol 1998; 72:7762-7771.
235. Rodriguez M, Quddus J. Effect of cyclosporin A, silica quartz and protease inhibitors on virus-induced demyelination. J Neuroimmunol 1986; 13:159-174.
236. Rossi CP, Delcroix M, Huitinga I, McAllister A, van Rooijen N, Claassen E, Brahic M. Role of macrophages during Theiler’s virus infection. J Virol 1997; 71:3336-3340.
237. Liuzzi MG, Riccio P, Dal Canto MC. Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler’s murine encephalomyelitis virus: Comparison between susceptible and resistant mice. J Neuroimmunol 1995; 62: 91-102.
238. Jelachich ML, Bramlage C, Lipton HL. Differentiation of M1 myeloid precursor cells into macrophages results in binding and infection by Theiler’s murine encephalomyelitis virus and apoptosis. J Virol 1999; 73:3227-3235.
239. Jelachich ML, Lipton HL. Theiler’s murine encephalomyelitis virus kills restrictive, but not permissive cells by apoptosis. J Virol 1996; 70:6856-6861.
240. Endoh M, Tabira T, Kunishita T, Sakai K, Yamamura T, Taketomi T. DM-20, a proteolipid apoprotein, is an encephalitogen of acute and relapsing autoimmune encephalomyelitis in mice. J Immunol 1986; 137:3832-3835.
241. Miller SD, Clatch RJ, Pevear DC, Trotter JL, Lipton HL. Class II-restricted T cell responses in Theiler’s murine encephalomyelitis virus (TMEV)-induced demyelinating disease: I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins. J Immunol 1987; 138:3776-3784.
242. Barbano RL, Dal Canto MC. Serum and cells from Theiler’s virus-infected mice fail to injure myelinating cultures or to produce in vivo transfer of disease: The pathogenesis of Theiler’s virus-induced demyelination appears to differ from that of EAE. J Neurol Sci 1984; 66: 283-293.
243. Miller SD, Gerety SJ, Kennedy MK, Peterson JD, Trotter JL, Touhy VK, Waltenbaugh C, Dal Canto MC, Lipton HL. Class II restricted T cell responses in Theiler’s murine encephalomyelitis virus (TMEV)-induced demyelinating disease: III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. J Neuroimmunol 1990; 26: 9-23.
244. Tan L-J, Kennedy MK, Dal Canto MC, Miller SD. Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance. J Immunol 1991; 147:1797-1802.
245. Miller SD, Tan L-J, Pope L, McRae B, Karpus WJ. Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis. Intern Rev Immunol 1992; 9:203-222. 35.
246. Tan L-J, Kennedy MK, Miller SD. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fince specificity of effector T cell inhibition. J Immunol 1992; 148:2748-2755.
247. Peterson JD, Karpus WJ, Clatch RJ, Miller SD. Split tolerance of Th1 and Th2 cells in tolerance to Theiler’s murine encephalomyelitis virus. Eur J Immunol 1993; 23:46-55.
248. Karpus WJ, Pope JG, Peterson JD, Dal Canto MC, Miller SD. Inhibition of Theiler’s virusinduced demyelination by peripheral immune tolerance induction. J Immunol 1995; 155: 947-957.
249. Miller SD, Vanderlugt CL, Smith W Begolka, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS. Persistent infection with Theiler’s virus leads to CNS autoimmunity via epitope spreading. Nature Med 1997; 10:1133-1136.
250. Dal Canto MC, Calenoff MA, Miller SD, Vanderlugt CL. Lymphocytes from mice chronically infected with Theiler’s murine encephalomyelitis virus (TMEV) produce demyelination of organotypic cultures after stimulation with the major encephalitogenic epitope of myelin proteolipid protein (PLP): Epitope spreading in TMEV infection has functional significance. J Neuroimmunol. In press.
251. Miller SD, Karpus WJ, Pope JG, Dal Canto MC, Melvold RW. Theiler’s virus-induced demyelinating disease. In: Cohen IR, Miller A, eds. Autoimmune Disease Models. San Diego and New York: Academic Press, 1994, pp. 23-38.
252. Peterson JD, Waltenbaugh C, Miller SD. IgG subclass response to Theiler’s murine encephalomyelitis virus infection and immunization suggest a dominant role for Th1 cells in susceptible mouse strains. Immunology 1992; 75:652-658.
253. Begolka WS, Vanderlugt CL, Rahbe SM, Miller SD. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J Immunol 1998; 161:4437-4446.
254. Sato S, Reiner SL, Jensen MA, Roos RP. Central nervous system cytokine mRNA expression following Theiler’s murine encephalomyelitis virus infection. J Neuroimmunol 1997; 76: 213-223.
255. Hoffman LM, Fife BT, Begolka WS, Miller SD, Karpus WJ. Central nervous system chemokine expression during Theiler’s virus-induced demyelinating disease. J Neurovirol 1999; 5:635-642.
256. Qi Y, Dal Canto MC. Effect of Theiler’s murine encephalomyelitis virus and cytokines on cultured oligodendrocytes and astrocytes. J Neurosci Res 1996;45:364-374.
257. Palma JP, Yauch RL, Lang S, Kim BS. Potential role of CD4+ T cell-mediated apoptosis of activated astrocytes in Theiler’s virus-induced demyelination. J Immunol 1999; 162:6543-6551.
258. Gerety SJ, Karpus WJ, Cubbon AR, Goswami RG, Rundell MK, Miller SD. Class II restricted T cell responses in Theiler’s murine encephalomyelitis virus-induced demyelinating disease: V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. J Immunol 1994; 152:908-918.
259. Gerety SJ, Rundell MK, Dal Canto MC, Miller SD. Class II restricted T cell responses in Theiler’s murine encephalomyelitis virus (TMEV) induced demyelinating disease: VI. Characteristics and fine specificity of an immuno-pathologic CD4+ T cell clone specific for an immunodominant VP2 epitope. J Immunol 1994; 152:919-929.
260. Roos RP, Stein S, Routbort M, Senkowski A, Bodwell T, Wollmann R. Theiler’s murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype. J Virol 1989; 63:4469-4473.
261. Zurbiggen A, Hogle J, Fujinami R. Alteration of aminoacid 101 within the capsid protein VP1 changes the pathogenicity of Theiler’s murine encephalomyelitis virus. J Exp Med 1989; 170:2037-2049.
262. Tangy F, McAllister A, Aubert C, Brahic M. Determinants of persistence and demyelination of the DA strain of Theiler’s virus are found only in the VP1 gene. J Virol 1991; 65:1616-1618.
263. Yauch RL, Kim BS. A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler’s virus is located within VP1(233-244). J Immunol 1994; 153:4508-4519.
264. Kim BS, Yauch RL, Bahk YY, Kang J-A, Dal Canto MC, Kappel Hall K. A spontaneous low-pathogenicity variant of Theiler’s virus contains an amino acid substitution within the predominant VP1 233-250 T-cell epitope. J Virol 1998; 72:1020-1027.
265. Yauch RL, Palma JP, Yahikozawa H, Koh CS, Kim BS. Role of individual T cell epitopes of Theiler’s virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response. J Virol 198; 72:6169-6174.
266. Rodriguez M, Lafuse WP, Leibowitz J, David CS. Partial suppression of Theiler’s virusinduced demyelination in vivo by administration of monoclonal antibodies to immuneresponse gene products (Ia antigens). Neurology 1986; 36:964-970.
267. Friedmann A, Frankel G, Lorch Y, Steinman L. Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler’s virus-infected mice: critical importance of timing of treatment. J Virol 1987; 61:898-903.
268. Welsh CJ, Tonks P, Nash AA, Blakemore WF. The effect of L3T4 T cell depletion on the pathogenesis of Theiler’s murine encephalomyelitis virus infection in CBA mice. J Gen Virol 1098; 68:1659-1667.
269. Rodriguez M, Sriram S. Successful therapy of Theiler’s virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J Immunol 1988; 140:2950-2955.
270. Wisniewski HM. Immunopathology of demyelination in autoimmune diseases and virus infection. Br Med Bull 1977; 33:54-59.
271. Brocke S, Gijbels K, Steinman L. Experimental autoimmune encephalomyelitis in the mouse. In: Cohen IR and Miller A, eds. Autoimmune Disease Models-A Guidebook. San Diego, CA: Academic Press, 1994, pp. 1-14.
272. Gooding LR, KA O’Connell. Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen. J Immunol 1983; 131:2580-2586.
273. Huber SA, Job LP, Woodruff JF. In vitro culture of coxsackievirus group B, type 3 immune spleen cells and biologic activity of the cultured cells in vivo. Infect Immun 1984; 43:567-570.
274. Fujinami RS, Oldstone MBA. Aminoacid homology and immune responses between the encephalitogenic site of myelin basic protein and virus: A mechanism for autoimmunity. Science 1985; 230:1043-1045.
275. Oldstone MBA, Notkins AL. Molecular mimicry. In: Notkins AL, Oldstone MBA, eds. Concepts in Viral Pathogenesis II. New York: Springer-Verlag, 1986, pp. 195-202.
276. Powell HC, Braheny SL, Hughes RAC, Lampert PW. Antigen-specific demyelination and significance of the bystander effect in peripheral nerves. Am J Pathol 1984; 114:443-453.
277. Wisniewski HM, Bloom BR. Primary demyelination as a nonspecific consequence of a cellmediated immune reaction. J Exp Med 1975; 141:346-359.
278. Holoshitz J, Naparstek J, Ben-Nun A, Marquardt P, Cohen IR. T Lymphocyte lines induce autoimmune encephalomyelitis, delayed hypersensitivity and bystander encephalitis and arthritis. Eur J Immunol 1984; 14:729-734.
279. Waksman B. Mechanisms in multiple sclerosis. Nature 1985; 318:104-105.
280. Booss J, Kim JH. Evidence for a viral etiology of multiple sclerosis. In: Cook SD ed. Handbook of Multiple Sclerosis. New York and Basel: Marcel Dekker, 1990, pp. 41-61.
281. Dal Canto MC, Rabinowitz SG, Johnson TC. Subacute infection with temperature-sensitive vesicular stomatitis virus mutant G41 in the central nervous system of mice:II. Immunofluorescent, morphologic and immunologic studies. J Infect Dis 1975; 139:36-51.
282. Dal Canto MC, Rabinowitz SG. Murine central nervous system infection by a viral temperature-sensitive mutant. Am J Pathol 1981; 102:412-426.
283. Dal Canto MC, Rabinowitz SG, Johnson TC. Virus-induced demyelination: Production by a viral temperature-sensitive mutant. J Neurol Sci 1979; 42:155-168.
284. Dal Canto MC, Rabinowitz SG. Central nervous system demyelination in Venezuelan equine encephalomyelitis virus infection: An experimental model of virus-induced myelin injury. J Neurol Sci 1981; 49:397-418.
285. Chew-Lim M, Suckling AJ, Webb HE. Demyelination in mice after two or three infections with avirulent Semliki Forest virus. Vet Pathol 1977;14:67-72.
286. Andrewes CH, Pereira HG, Wildy P. Togaviridae. In: Andrewes CH, Pereira HG, Wildy P, eds. Viruses of Vertebrates. London: Bailliere Tindall, 1978, pp. 67-118.
287. Smithburn KC, Haddow AJ. Semliki Forest virus: I. Isolation and pathogenic properties. J Immunol 1944;49:141-148.
288. Sheahan BJ, Barrett PN, Atkins GJ. Demyelination in mice resulting from infection with a mutant of Semliki Forest virus. Acta Neuropathol (Berl) 1981; 53:129-136.
289. Sheahan BJ, Gates MC, Caffrey JF, Atkins GJ. Oligodendrocyte infection and demyelination produced in mice by the M9 mutant of Semliki Forest virus. Acta Neuropathol (Berl) 1983; 60:257-265.
290. Jagelman S, Suckling AJ, Webb HE, Bowen ETW. The pathogenesis of avirulent Semliki Forest virus infections in athymic nude mice. J Gen Virol 1978; 41:599-607.
291. Fazakerley JK, Amor S, Webb HE. Reconstitution of Semliki Forest virus infected mice induces immune mediated pathological changes in the CNS. Clin Exp Immunol 1983; 52: 115-120.
292. Pathak S, Illavia SJ, Webb HE. The identification and role of cells involved in CNS demyelination in mice after Semliki Forest infection: An ultrastructural study. Immunology of the nervous system. Progr Br Res 1983; 59:237-254.
293. Illavia SJ, Webb HE. The pathological effect on the central nervous system of mice following single and repeated infections of the demyelinating A7(74) strain of Semliki Forest virus. Neuropathol Appl Neurobiol 1988; 14:207-220.
294. Berger ML. Humoral and cell mediated immune mechanisms in the production of pathology in avirulent Semliki Forest virus encephalitis. Infect Immun 1980; 30:244-253.
295. Chew-Lim M, Scott T, Webb HE. An ultrastructural study of cerebellar lasions induced in mice by three inoculations of avirulent Semliki Forest virus. Acta Neuropathol (Berl) 1978; 41:55-59.
296. Kelly WR, Blakemore WF, Jagelman S, Webb HE. Demyelination induced in mice by avirulent Semliki Forest virus: Part 2. An ultrastructural study of focal demyelination in the brain. Br J Exp Pathol 1982; 2:43-53.
297. Webb HE, Chew-Lim M, Jagelman S, Oaten SW, Pathak S, Suckling AJ, Mackenzie A. Semliki Forest virus infection in mice as a model for studying acute and chronic CNS virus infections in man. In: Clifford Rose F, ed. Clinical Neuroimmunology. Oxford, UK: Blackwell Scientific Publications, 1979, pp. 369-390.
298. Chew-Lim M, Webb HE, Jagelman S. The effect of irradiation on demyelination induced by avirulent Semliki Forest virus. Br J Exp Pathol 1977; 58:459-464.
299. Fazakerley JK, Webb HE. Semliki Forest virus induced, immune mediated demyelination: The effect of irradiation. Br J Exp Pathol 1987; 68:101-113.
300. Amor S, Webb HE. The effect of cycloleucine on SFV A7(74) infection in mice. Br J Exp Pathol 1987; 68:225-235.
301. Fazakerley JK, Webb HE. Semliki Forest virus-induced, immune-mediated demyelination: Adoptive transfer studies and viral persistence in nude mice. J Gen Virol 1987; 68:377-385.
302. Webb HE, Mehta S, Gregson NA, Leibowitz S. Immunological reaction of the demyelinating Semliki Forest virus with immune serum to glycolipids and its possible importance to central nervous system viral auto-immune disease. Neuropathol Appl Neurobiol 1984;10:77-84.
303. Khalili-Shirazi A, Gregson N, Webb HE. Immunological relationship between a demyelinating RNA enveloped budding virus (Semliki Forest) and brain glycolipids. J Neurol Sci 1986; 76:91-103.
304. Evans NRS, Webb HE. Immunoelectron-microscopical labelling of glycolipids in the envelope of a demyelinating brain-derived RNA virus (Semliki Forest) by anti-glycolipid sera. J Neurol Sci 1986; 74:279-287.
305. Atkins GJ, Sheahan BJ. Semliki Forest virus neurovirulence mutants have altered cytopathogenicity for central nervous system cells. Infect Immun 1982; 36:333-341.
306. Mokhtarian F, Swoveland P. Predisposition to EAE induction in resistant mice by prior infection with Semliki Forest virus. J Immunol 1987; 138:3264-3268.
307. Wu L-X, Mäkelä MJ, Roÿttä M, Salmi A. Effect of viral infection on experimental allergic encephalomyelitis in mice. J Neuroimmunol 1988; 18:139-153.
308. Eralinna JP, Soilu-Hanninen M, Roytta M, Ilonen J, Makela A, Salonen R. Facilitation of experimental allergic encephalomyelitis by irradiation and virus infection: role of inflammatory cells. J Neuroimmunol 1994; 55:81-90.
309. Soilu-Hanninen M, Eralinna JP, Hukkanen V, Roytta M, Salmi A, Salonen R. Semliki Forest virus infects mouse brain endothelial cells and causes blood-brain barrier damage. J Virol 1994; 68:6291-6298.
310. Mokhtarian F, Zhang Z, Shi Y, Gonzales E, Sobel RA. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J Neuroimmunol 1999; 95:43-54.
311. Jenkins HG, Tansey EM, Macefield F, Ikeda H. Evidence for a T-cell related factor as the cause of demyelination in mice following Semliki Forest virus infection. Br Res 1988; 459: 145-147.
312. Butt AM, Tutton MG, Kirvell SL, Amor S, Jenkins HG. Morphology of oligodendrocytes during demyelination in optic nerves of mice infected with Semliki Forest virus. Neuropathol Appl Neurobiol 1996; 22:540-547.
313. Mokhtarian F, Shi Y, Zhu PF, Grob D. immune responses and autoimmune oucome during virus infection of the central nervous system. Cell Immunol 1994; 157:195-210.
314. Subak-Sharpe I, Dyson H, Fazakerley JK. In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection. J Virol 1993; 67:7629-7633.
315. Morris MM, Dyson H, Baker D, Harbige LS, Fazakerley JK, Amor S. Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection. J Neuroimmunol 1997; 74: 185-197.
316. Donnelly SM, Sheahan BJ, Atkins GJ. Long term effects of Semliki Forest virus infection in the mouse central nervous system. Neuropathol Appl Neurobiol 1997; 23:235-241.
317. Grosfeld H, Velan B, Leitner M, Lustig S, Lachi BE, Cohen S, Shafferman A. Delineation of protective epitopes on the E2-envelope glycoprotein of Semliki Forest virus. Vaccine 1991; 9: 451-456.
318. Grosfeld H, Lustig S, Gozes Y, Velan B, Cohen S, Leitner M, Lachmi B, Katz D, Olshevski U, Shafferman A. Divergent envelope E2 alphavirus sequences spanning amino acids 297 to 352 induce in mice virus-specific protective immunity and antibodies with complementmediated cytolytic activity. J Virol 1992; 66:1084-1090.
319. Snijders A, Benaissa-Trouw BJ, Visser-Vernooy HJ, Fernandez I, Snippe H, Kraaijeveld CA. A delayed-type hypersensitivity-inducing T cell epitope of Semliki Forest virus mediates effective T-helper activity for antibody production. Immunology 1992; 77:322-329.
320. Glasgow GM, Sheahan BJ, Atkins GJ, Wahlberg JM, Salminen A, Liljestrom P. Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice. Virology 1991; 185:741-748.
321. Glasgow GM, Killen HM, Liljestrom P, Sheahan BJ, Atkins GJ. A single amino acid change in the E2 spike protein of a virulent strain of Semliki Forest virus attenuates pathogenicity. J Gen Virol 1994; 75: 663-668.
322. Tarbatt CJ, Glasgow GM, Mooney DA, Sheahan BJ, Atkins GJ. Sequence analysis of the avirulent, demyelinating A7 strain of Semliki Forest virus. J Gen Virol 1997; 78:1551-1557.
323. Kurtzke JF. Epidemiologic contributions to multiple sclerosis: Am overview. Neurology 1980; 30:61-79.
324. Forghani B, Cremer NE, Johnson KB, Ginsberg AH, Likosky WH. Viral antibodies in cerebrospinal fluid of multiple sclerosis and control patients: Comparison between radioimmunoassay and conventional standards. J Clin Microbiol 1978; 7:63-69.
325. McFarlin DE, McFarland HF. Multiple sclerosis. N Engl J Med 1982; 307:1183-1188 and 1246-1251.
326. Johnson RT. The possible viral etiology of multiple sclerosis. In: Friedlander WJ, ed. Advances in Neurology, New York: Raven, (1975), vol. 13, pp. 1-46.
327. Prineas JW. Pathology of multiple sclerosis. In: Cook SD, ed. Handbook of Multiple Sclerosis. New York and Basel: Marcel Dekker, 1990:87-218.
328. Batchelor JR, Compston A, McDonald WI. The significance of the association between HLA and multiple sclerosis. Br Med Bull 1978; 34: 279-284.
329. Poser CM. The pathogenesis of multiple sclerosis: Additional considerations. J Neurol Sci 1993; 115(suppl):S3-S15.
330. Sadovnick AD. Genetic epidemiology of multiple sclerosis. Ann Neurol 1994; 36(S2):S194-S203.